432 related articles for article (PubMed ID: 19208511)
1. Efficacy and safety of moderately steatotic donor liver in transplantation.
Gao F; Xu X; Ling Q; Wu J; Zhou L; Xie HY; Wang HP; Zheng SS
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):29-33. PubMed ID: 19208511
[TBL] [Abstract][Full Text] [Related]
2. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
3. Expanding postmortem donor pool using steatotic liver grafts: a new look.
Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
[TBL] [Abstract][Full Text] [Related]
5. Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Fonseca LE; Motta TD; Pandullo FL; Rezende MB; Meira-Filho SP; Sá JR; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2516-8. PubMed ID: 17954162
[TBL] [Abstract][Full Text] [Related]
6. Assignment of steatotic livers by the Mayo model for end-stage liver disease.
Briceño J; Padillo J; Rufián S; Solórzano G; Pera C
Transpl Int; 2005 May; 18(5):577-83. PubMed ID: 15819807
[TBL] [Abstract][Full Text] [Related]
7. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
9. Critical use of extended criteria donor liver grafts in adult-to-adult whole liver transplantation: a single-center experience.
Gruttadauria S; Vizzini G; Biondo D; Mandalà L; Volpes R; Palazzo U; Gridelli B
Liver Transpl; 2008 Feb; 14(2):220-7. PubMed ID: 18236398
[TBL] [Abstract][Full Text] [Related]
10. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
[TBL] [Abstract][Full Text] [Related]
11. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
12. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term outcomes after steatotic liver transplantation.
Doyle MB; Vachharajani N; Wellen JR; Anderson CD; Lowell JA; Shenoy S; Brunt EM; Chapman WC
Arch Surg; 2010 Jul; 145(7):653-60. PubMed ID: 20644128
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation following donation after cardiac death: an analysis using matched pairs.
Pine JK; Aldouri A; Young AL; Davies MH; Attia M; Toogood GJ; Pollard SG; Lodge JP; Prasad KR
Liver Transpl; 2009 Sep; 15(9):1072-82. PubMed ID: 19718634
[TBL] [Abstract][Full Text] [Related]
15. Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation.
Bjøro K; Ericzon BG; Kirkegaard P; Höckerstedt K; Söderdahl G; Olausson M; Foss A; Schmidt LE; Isoniemi H; Brandsaeter B; Friman S
Transplantation; 2003 Feb; 75(3):347-53. PubMed ID: 12589157
[TBL] [Abstract][Full Text] [Related]
16. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm.
Chavin KD; Taber DJ; Norcross M; Pilch NA; Crego H; McGillicuddy JW; Bratton CF; Lin A; Baliga PK
Clin Transplant; 2013; 27(5):732-41. PubMed ID: 23991646
[TBL] [Abstract][Full Text] [Related]
17. Longterm outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases.
Hong JC; Yersiz H; Farmer DG; Duffy JP; Ghobrial RM; Nonthasoot B; Collins TE; Hiatt JR; Busuttil RW
J Am Coll Surg; 2009 May; 208(5):682-9; discusion 689-91. PubMed ID: 19476815
[TBL] [Abstract][Full Text] [Related]
18. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
[TBL] [Abstract][Full Text] [Related]
19. Effect of graft steatosis on liver function and organ survival after liver transplantation.
Angele MK; Rentsch M; Hartl WH; Wittmann B; Graeb C; Jauch KW; Loehe F
Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767
[TBL] [Abstract][Full Text] [Related]
20. Using elderly donors in liver transplantation.
Grazi GL; Ravaioli M; Zanello M; Ercolani G; Cescon M; Varotti G; Del Gaudio M; Vetrone G; Lauro A; Ramacciato G; Pinna AD
Transplant Proc; 2005; 37(6):2582-3. PubMed ID: 16182750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
